Integrated analysis reveals the molecular features of fibrosis in triple-negative breast cancer: Molecular Therapy - Oncolytics
Challenges and perspectives in the treatment of diabetes associated breast cancer - ScienceDirect
Cancers | Free Full-Text | From Immunohistochemistry to New Digital Ecosystems: A State-of-the-Art Biomarker Review for Precision Breast Cancer Medicine
What Breast Medical Oncologists Need From Pathologists: Overview, Tumor Size, Histologic Grade
Interval Breast Cancer Rates and Tumor Characteristics in the Prospective Population-based Malmö Breast Tomosynthesis Screening Trial | Radiology
Frontiers | Advanced Approaches to Breast Cancer Classification and Diagnosis
Cancers | Free Full-Text | Epigenetics in Breast Cancer Therapy—New Strategies and Future Nanomedicine Perspectives
Molecular testing in breast cancer. | Semantic Scholar
Frontiers | A Phenomic Perspective on Factors Influencing Breast Cancer Treatment: Integrating Aging and Lifestyle in Blood and Tissue Biomarker Profiling
Targeting cancer stem cells for reversing therapy resistance: mechanism, signaling, and prospective agents | Signal Transduction and Targeted Therapy
Tumor Markers of Breast Cancer: Role in Early Diagnosis, Monitoring Response to Therapy and Determination of Prognosis
Tumor marker serum concentrations in patients with primary locoregional... | Download Table
Clinical and molecular characteristics of HER2-low-positive breast cancer: pooled analysis of individual patient data from four prospective, neoadjuvant clinical trials - The Lancet Oncology
Role of hormone receptors and HER2 as prospective molecular markers for breast cancer: An update - ScienceDirect
Tumor Markers for Breast Cancer: Benefits, Drawbacks, Results & More
Breast cancer markers | Download Table
The prognostic significance of preoperative tumor marker (CEA, CA15-3) elevation in breast cancer patients: data from the Korean Breast Cancer Society Registry | SpringerLink
Existing noninvasive tumor markers that are in routine clinical use for... | Download Table
The costs of tumor marker tests in early-stage breast cancer survivors
DNA methylation markers predict recurrence-free interval in triple-negative breast cancer | npj Breast Cancer
Cancers | Free Full-Text | Predictive Biomarkers of Response to Neoadjuvant Chemotherapy in Breast Cancer: Current and Future Perspectives for Precision Medicine
PDF) Tumor markers of breast cancer: New prospectives
Tumor Protein p53: Novel Aspects of an Old Tumor Marker | Semantic Scholar
Cancers | Free Full-Text | Peripheral Blood Transcriptome in Breast Cancer Patients as a Source of Less Invasive Immune Biomarkers for Personalized Medicine, and Implications for Triple Negative Breast Cancer
